JPT2 and esophageal squamous cell carcinoma: Low expressions of both HN1L and Ki67 were indicated in tumors originating from HN1L-silenced KYSE150 cells (Fig. 3J), suggesting the oncogenic role of HN1L in ESCC progression by enhancing cell proliferation.